Torrent Pharma is benefiting from robust growth in the domestic market and healthy performance across key geographies, while synergies from JB Chemicals acquisition are expected to support earnings
Torrent Pharma is benefiting from robust growth in the domestic market and healthy performance across key geographies, while synergies from JB Chemicals acquisition are expected to support earnings
<iframe src="https://hindustansphere.com/embed/cluster/c09c82e103174b6dafb7725196cb65945e092148" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Strong domestic market growth, margins to drive gains for Torrent Pharma"></iframe>
